Malignant ascites: a 2-year review from a teaching hospital

Simon L. Parsons, Martin W. Lang, Robert J. C. Steele

    Research output: Contribution to journalArticlepeer-review

    97 Citations (Scopus)


    In this retrospective review of 164 consecutive patients with malignant ascites it has been shown that ovarian ascites accounts for 28% of the total and is associated with a significantly improved survival compared with other groups (P<0.001). Non-ovarian ascites is associated with a very poor prognosis and many patients in this group are unsuitable for aggressive treatment. In 49% of patients, ascites will be the presenting feature requiring further investigation to ascertain the primary tumour. Thorough investigation of female patients should be performed in order to identify all patients with an ovarian primary so that appropriate chemotherapy can be given. However, thorough investigation in male patients is not justifiable.
    Original languageEnglish
    Pages (from-to)237-239
    Number of pages3
    JournalEJSO - European Journal of Surgical Oncology
    Issue number3
    Publication statusPublished - Jun 1996


    • Adult
    • Aged
    • Ascites
    • Breast Neoplasms
    • Digestive System Neoplasms
    • Female
    • Humans
    • Male
    • Middle Aged
    • Neoplasms
    • Ovarian Neoplasms
    • Prognosis
    • Retrospective Studies
    • Survival Rate


    Dive into the research topics of 'Malignant ascites: a 2-year review from a teaching hospital'. Together they form a unique fingerprint.

    Cite this